Simultaneous expression of mutant KrasG12D expression and mutant p53R172H — in the model known as KPC — results in the development of metastatic pancreatic cancer with high penetrance and a latency of only a few months (11) as mutant p53 bypasses oncogene-induced senescence (12). This evidence concerns the gene TP53 and pancreatic neoplasm.